Martin Akerman

Envisagenics’ artificial intelligence wows real investors

By GREGORY ZELLER // They’re on a major roll at Envisagenics Inc., a Cold Spring Harbor Laboratory spinoff that’s piling up some hefty research grants. Now based in New York City, the biotech announced this week that it’s been awarded a $1.5 million Small Business Innovation Research Phase II grant from the National Institutes of Health – the second time the NIH has backed the data-crunching startup. The new award is earmarked for the continued…


Helping Big Pharma master Big Data

By GREGORY ZELLER // Medicine is making giant strides in the research of ribonucleic acid – RNA for short – a molecule that plays vital roles in the coding, decoding and regulation of genes. The stumbling block is the resulting data, which has been piling up from next-generation sequencing technology and will soon represent the largest collection of electronic bytes in the world, topping even the astronomical amounts of data collected on space. And even…